U.S. markets open in 8 hours 8 minutes
  • S&P Futures

    4,198.75
    +4.50 (+0.11%)
     
  • Dow Futures

    34,467.00
    +25.00 (+0.07%)
     
  • Nasdaq Futures

    13,633.00
    +35.25 (+0.26%)
     
  • Russell 2000 Futures

    2,239.90
    0.00 (0.00%)
     
  • Crude Oil

    65.10
    +0.39 (+0.60%)
     
  • Gold

    1,820.70
    +5.00 (+0.28%)
     
  • Silver

    27.59
    +0.12 (+0.43%)
     
  • EUR/USD

    1.2071
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5610
    0.0000 (0.00%)
     
  • Vix

    18.39
    -0.76 (-3.97%)
     
  • GBP/USD

    1.3907
    +0.0014 (+0.10%)
     
  • USD/JPY

    109.0700
    -0.0150 (-0.01%)
     
  • BTC-USD

    55,888.87
    -1,138.04 (-2.00%)
     
  • CMC Crypto 200

    1,448.78
    -22.63 (-1.54%)
     
  • FTSE 100

    7,076.17
    +36.87 (+0.52%)
     
  • Nikkei 225

    29,378.12
    +46.75 (+0.16%)
     

Skylight Health Announces New OTCQX Ticker and Presentation at LD Micro in December

  • Oops!
    Something went wrong.
    Please try again later.
Skylight Health Group Inc.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Skylight Health will begin trading under new ticker “SHGFF” on the OTCQX December 9, 2020

  • Company continues to trade under “SHG” on the Canadian Securities Exchange

  • Company announces its participation and presentation at the LD Micro conference December 15, 2020

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (CSE:SHG; OTCQX: CBIIF) (“SHG” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, announces that it will begin trading on the OTCQX under new ticker symbol “SHGFF” at the start of trading December 9, 2020. The Company continues to trade on the Canadian Securities Exchange under symbol “SHG”.

The Company also announces that CEO, Prad Sekar will be presenting at the LD Micro conference on December 15, 2020 at 11:20am EST on Track 1.

LD Micro plays host to one of the most influential conferences in the small-cap world. With the recent SRAX acquisition, LD has access to the largest active base of micro-cap investors in the world at over 2 million and growing. To register for this virtual conference, visit the link here.

About Skylight Health Group

Skylight Health Group (CSE:SHG OTCQX:CBIIF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. With a patient roster of over 120,000 patients, the Company’s operations spread across 14 states and continues to expand in services and locations both organically and by way of strategic acquisitions.

The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.

For more information, please visit www.skylighthealthgroup.com or contact:

Investor Relations
Jonathan L. Robinson CFA
Oak Hill Financial
jrobinson@oakhillfinancial.ca
416-669-1001

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health’s filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding the Company’s unaudited financial results and projected growth.

Although Skylight Health as attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are subject to inconsistent legislation and regulation; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and recreational-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.

No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.